Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM PAR NO PAR
-
Total 13F shares
-
7,048,122
-
Share change
-
-134,106
-
Total reported value
-
$116,418,000
-
Price per share
-
$16.75
-
Number of holders
-
32
-
Value change
-
-$1,246,355
-
Number of buys
-
13
-
Number of sells
-
12
Institutional Holders of CYNAPSUS THERAPEUTICS INC - COM PAR NO PAR (CYNA) as of Q2 2016
As of 30 Jun 2016,
CYNAPSUS THERAPEUTICS INC - COM PAR NO PAR (CYNA) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,048,122 shares.
The largest 10 holders included
FRANKLIN RESOURCES INC, ORBIMED ADVISORS LLC, Aisling Capital LLC, Visium Asset Management, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., Tekla Capital Management LLC, NEXTHERA CAPITAL LP, DAFNA Capital Management LLC, PURA VIDA INVESTMENTS, LLC, and First Light Asset Management, LLC.
This page lists
32
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.